Anatomy & Physiology Study Guide
26

The Lymphatic and Immune Systems

Chapter 26Fluids and Transport7.5 h5 sections, outcomes 1-27Week 20

Slide deck, 27 slidesFlashcards, 77Practice questions, 54 in the bank

26.1

Lymphatic Vessels, Lymph Formation, and Lymphoid Organs

2 hMonday, Mar 29, Week 20

Outcomes

  1. 1Trace lymph from an interstitial initial lymphatic through collecting vessels, nodes and trunks to the venous angle.
  2. 2Distinguish the territories drained by the thoracic duct from those drained by the right lymphatic duct.
  3. 3Explain how interstitial pressure, smooth-muscle pumping, skeletal-muscle action and valves generate and direct lymph flow.
  4. 4Describe the cortex, paracortex and medulla of a lymph node and the route of lymph and cells through it.
  5. 5Identify the red pulp, white pulp and periarteriolar lymphoid sheath of the spleen on a section.
  6. 6Identify the cortex, medulla and Hassall corpuscles of the thymus and state the role of the thymic epithelium.
  7. 7Identify the sentinel nodes of the breast, upper limb and head and neck and relate them to cancer staging.

Outline

  1. A

    Lymph formation and function

    1. Net capillary filtration leaves about 2-4 L/day spot-check of fluid and plasma protein in the interstitium that venules cannot reabsorb; lymphatics return it.
    2. Initial lymphatics are blind-ended, with overlapping endothelial flaps anchored by filaments; interstitial swelling opens the flaps and fluid enters.
    3. Lymph carries protein back to blood, absorbs dietary fat as chyle through intestinal lacteals, and delivers antigen and dendritic cells to nodes.
    4. Interstitial pressure, intrinsic smooth-muscle contraction of collecting vessels, skeletal-muscle and respiratory pumps, and one-way valves drive flow.
    5. Lymphedema results from obstruction or removal of nodes (filariasis, radiation, axillary dissection).
  2. B

    Lymph vessels and drainage territories

    1. Vessel hierarchy: initial lymphatics, precollectors, collecting vessels with valves, lymph trunks, then two ducts.
    2. Thoracic duct starts at the cisterna chyli (L1-L2), crosses the aortic hiatus at T12, ascends right of midline and crosses to the left at about T5.
    3. Thoracic duct drains both lower limbs, abdomen, pelvis, left thorax, left upper limb and left head and neck, and empties at the left venous angle.
    4. Right lymphatic duct drains the right upper limb, right thorax and right head and neck, entering the right venous angle (about the right 1/4 of the body).
    5. Thoracic duct injury (neck surgery, esophagectomy) causes chylothorax or chyle leak.
  3. C

    Lymph node microanatomy

    1. Capsule and trabeculae enclose the cortex (B-cell follicles and germinal centres), the paracortex (T cells and dendritic cells) and the medulla (cords and sinuses with plasma cells).
    2. Several afferent vessels pierce the capsule; subcapsular and cortical sinuses lead to medullary sinuses and one efferent vessel at the hilum.
    3. High endothelial venules in the paracortex are the entry point for circulating lymphocytes.
    4. Reactive nodes enlarge with germinal-centre hyperplasia; metastatic nodes are firm, fixed and painless.
  4. D

    Spleen, thymus and MALT

    1. Spleen white pulp: PALS (T cells) around the central artery, follicles (B cells) and marginal zone; red pulp: splenic cords of Billroth and sinusoids.
    2. Spleen filters blood, removes aged red cells and opsonised bacteria, and stores platelets; asplenia predisposes to encapsulated organisms (Streptococcus pneumoniae, Haemophilus, Neisseria).
    3. Thymus is largest in childhood, lies in the anterior superior mediastinum and involutes with age; cortex is dense with thymocytes, medulla is paler with Hassall corpuscles.
    4. The blood-thymus barrier shields cortical thymocytes; cortical epithelium mediates positive selection and medullary epithelium (AIRE) negative selection.
    5. MALT includes palatine, pharyngeal and lingual tonsils (Waldeyer ring), Peyer patches and appendix; tonsils have crypts and no afferent lymphatics.
  5. E

    Regional drainage and sentinel nodes

    1. Breast: about 75% of lymph spot-check drains to axillary nodes (anterior/pectoral, lateral, central, apical); medial breast also drains to parasternal nodes.
    2. Sentinel node is the first node receiving drainage from a tumour; its biopsy stages breast cancer and melanoma and spares full dissection.
    3. Head and neck: submental, submandibular, deep cervical chain, with the jugulo-omohyoid node draining the tongue; left supraclavicular (Virchow) node signals abdominal malignancy.
    4. Lower limb and perineum drain to inguinal nodes; pelvic viscera to iliac nodes then para-aortic nodes.

Lab

  • Label the thoracic duct, cisterna chyli, right lymphatic duct and venous angles on NET plate 7 with labels covered.
  • Histology Guide MH-076-077-078 lymph node: find capsule, subcapsular sinus, cortical follicle with germinal centre, paracortex, medullary cords and sinuses.
  • Histology Guide MH-085 spleen: separate white pulp, central arteriole and red pulp; R&P plates 35-36.
  • Histology Guide MH-079 thymus and R&P plate 37: distinguish cortex from medulla and find Hassall corpuscles.
  • Histology Guide MH-081a palatine tonsil and R&P plate 32: find stratified squamous crypt epithelium and lymphoid follicles.
  • Trace axillary node groups and breast drainage on NET plates 190-191; list the first node for each quadrant.
26.2

Innate Immunity

1 hTuesday, Mar 30, Week 20

Outcomes

  1. 8Classify the physical, chemical and microbiological barriers that make up the first line of defence.
  2. 9Compare pattern-recognition receptors (TLR, NLR, RLR) by location and ligand.
  3. 10Distinguish the classical, lectin and alternative complement pathways by trigger and shared effector steps.
  4. 11Describe the roles of neutrophils, macrophages, NK cells and dendritic cells in innate defence.
  5. 12Explain how histamine, prostaglandins, bradykinin and cytokines produce the cardinal signs of inflammation.

Outline

  1. A

    Barriers and cells

    1. Skin keratin, low pH, sebum, lysozyme in tears and saliva, defensins, mucociliary clearance and commensal flora block entry.
    2. Neutrophils are first responders and phagocytose by respiratory burst and NETs; monocytes become tissue macrophages.
    3. NK cells kill cells that lack MHC I or display stress ligands, using perforin and granzymes.
    4. Dendritic cells link innate and adaptive immunity by carrying antigen to nodes.
  2. B

    Pattern recognition

    1. Pathogen-associated molecular patterns (PAMPs) such as LPS, flagellin and dsRNA are sensed by germline-encoded receptors.
    2. TLRs sit on the cell surface or in endosomes (TLR4 binds LPS, TLR3 binds dsRNA, TLR9 binds CpG DNA).
    3. NLRs and RLRs sense cytosolic ligands; NLRP3 inflammasome activates caspase-1 and releases IL-1 beta.
    4. Signalling through MyD88 and NF-kB drives TNF-alpha, IL-1 and IL-6 and type I interferon release.
  3. C

    Complement

    1. Classical pathway is triggered by IgM or IgG bound to antigen (C1q); lectin pathway by mannose-binding lectin; alternative by spontaneous C3 hydrolysis on microbes.
    2. All three converge on C3 convertase, which cleaves C3 into C3a and C3b.
    3. C3b opsonises, C3a and C5a are anaphylatoxins and C5a is chemotactic; C5b-C9 forms the membrane attack complex.
    4. C1 inhibitor deficiency causes hereditary angioedema; terminal-component deficiency predisposes to Neisseria infection.
  4. D

    Inflammation

    1. Mast cell histamine and prostaglandins cause vasodilation (redness, heat) and increased permeability (swelling).
    2. Bradykinin and prostaglandin E2 sensitise nociceptors (pain); IL-1 and TNF-alpha raise the hypothalamic set point (fever).
    3. Leukocyte emigration: selectin rolling, integrin adhesion, diapedesis, chemotaxis along IL-8 and C5a gradients.
    4. Acute-phase proteins (CRP, fibrinogen, serum amyloid A) rise in response to IL-6 from the liver.

Lab

  • Draw the three complement pathways converging on C3 convertase and label every anaphylatoxin, opsonin and MAC component.
  • Diagram diapedesis showing selectin, integrin and chemokine steps.
26.3

Adaptive Immunity: Antigens, MHC, and T Lymphocytes

2 hWednesday, Mar 31, Week 20

Outcomes

  1. 13Compare MHC class I and class II molecules by structure, cell distribution and the T-cell co-receptor each engages.
  2. 14Distinguish the endogenous (cytosolic) from the exogenous (endosomal) antigen-processing pathway.
  3. 15Describe the roles of CD4 helper subsets (Th1, Th2, Th17, Treg, Tfh) and CD8 cytotoxic T cells.
  4. 16Explain why TCR engagement needs co-stimulation (CD28 with B7) and what anergy means.
  5. 17Outline V(D)J recombination and how it generates receptor diversity.
  6. 18Explain clonal selection and clonal expansion of antigen-specific lymphocytes.

Outline

  1. A

    Antigens and receptor diversity

    1. Antigens are recognised by an epitope; haptens are immunogenic only when bound to a carrier protein.
    2. Antigen receptors are assembled in developing lymphocytes by RAG1/RAG2-mediated V(D)J recombination of gene segments.
    3. Junctional diversity from N-nucleotide addition by TdT and pairing of two chains yield 10^9-10^11 spot-check distinct receptors.
    4. T-cell receptors are alpha-beta (most) or gamma-delta heterodimers, and recognise peptide only when displayed on MHC.
  2. B

    MHC and antigen processing

    1. MHC I (HLA-A, B, C) is expressed on all nucleated cells; it binds CD8 and presents peptides of 8-10 residues from cytosolic proteins.
    2. Endogenous pathway: proteasome, TAP transporter into the ER, loading with beta-2-microglobulin, surface display.
    3. MHC II (HLA-DR, DP, DQ) is found on dendritic cells, macrophages and B cells; it binds CD4 and presents longer peptides (13-25 residues) from phagocytosed protein.
    4. Exogenous pathway: endosome acidification, invariant chain removal by HLA-DM, loading of MHC II in the late endosome.
    5. Cross-presentation by dendritic cells lets exogenous antigen reach MHC I; HLA associations include B27 with ankylosing spondylitis.
  3. C

    T-cell development and activation

    1. Thymocytes progress from double-negative to double-positive (CD4+CD8+) to single-positive stages in the thymus.
    2. Signal 1 is TCR-peptide-MHC; signal 2 is B7 on the antigen-presenting cell with CD28 on the T cell; signal 3 is cytokine polarisation.
    3. Absence of signal 2 induces anergy; CTLA-4 and PD-1 deliver inhibitory signals and are checkpoint-inhibitor targets.
    4. IL-2 drives clonal expansion; effector and memory subsets then arise.
  4. D

    T-cell subsets and effectors

    1. Th1 (IFN-gamma) activates macrophages and intracellular killing; Th2 (IL-4, IL-5, IL-13) drives IgE and eosinophils.
    2. Th17 (IL-17) recruits neutrophils; Tfh assist germinal-centre B cells; Treg (FOXP3, IL-10, TGF-beta) suppress responses.
    3. CD8 cells kill via perforin and granzyme, which activate caspases, and via Fas-FasL.
    4. HIV kills CD4 cells; AIDS is defined by CD4 below 200 cells/uL spot-check or opportunistic infection.
  5. E

    Clonal selection

    1. Each lymphocyte carries one specificity; antigen selects the cells that already bind it.
    2. Selected clones proliferate and differentiate into effectors and memory cells.

Lab

  • Draw side by side the MHC I and MHC II pathways with each organelle, transporter and co-receptor labelled.
  • Make a table of T-cell subsets with their cytokines, transcription factors and targets.
26.4

B Lymphocytes, Antibodies, and Humoral Immunity

1.5 hThursday, Apr 1, Week 20

Outcomes

  1. 19Describe B-cell activation by T-dependent and T-independent antigens, including class switching and somatic hypermutation.
  2. 20Compare IgG, IgM, IgA, IgE and IgD by structure, location and function.
  3. 21Relate antibody Fab and Fc regions to neutralisation, opsonisation and complement activation.
  4. 22Contrast the plasma cell and memory B cell fates of germinal-centre selection.

Outline

  1. A

    B-cell activation

    1. Naive B cell binds antigen with surface IgM/IgD, internalises it and presents peptide on MHC II to a Tfh cell.
    2. CD40-CD40L contact and IL-4/IL-21 drive germinal-centre reaction.
    3. T-independent antigens (polysaccharides) cross-link receptors and make mostly IgM with little memory.
    4. Somatic hypermutation by AID plus selection yields affinity maturation; AID also drives class switching.
    5. X-linked agammaglobulinaemia (BTK defect) removes B cells; CD40L deficiency causes hyper-IgM syndrome.
  2. B

    Antibody structure and classes

    1. Two heavy and two light chains joined by disulphide bonds; variable regions form the Fab antigen site, constant heavy regions form Fc.
    2. IgG (about 75% of serum Ig spot-check) crosses the placenta, opsonises and activates complement.
    3. IgM is a pentamer and first responder with the best complement fixation; IgA is a secretory dimer in mucosal fluids and milk.
    4. IgE binds mast cells through FcεRI and defends against helminths; IgD is largely a naive B-cell receptor.
  3. C

    Effector functions

    1. Neutralisation blocks toxin or viral binding; opsonisation lets phagocytes bind through Fc receptors.
    2. Antibody-dependent cellular cytotoxicity is mediated by NK cells through CD16.
    3. Complement activation through C1q gives lysis and opsonin deposition.

Lab

  • Draw an IgG monomer, labelling heavy, light, V and C domains, Fab, Fc and hinge, then add the secretory-IgA and pentameric-IgM forms.
26.5

Immunological Memory, Hypersensitivity, Tolerance, and Immunodeficiency

1 hThursday, Apr 1, Week 20

Outcomes

  1. 23Compare the kinetics, dominant isotype and affinity of the primary and secondary antibody responses.
  2. 24Classify type I to IV hypersensitivity by mediator, timing and a clinical example.
  3. 25Distinguish central from peripheral tolerance and give a mechanism for each.
  4. 26Compare hyperacute, acute and chronic transplant rejection.
  5. 27Differentiate primary immunodeficiencies from acquired ones.

Outline

  1. A

    Primary vs secondary response

    1. Primary: lag of 5-10 days spot-check, IgM first then IgG, modest titre and affinity.
    2. Secondary: faster (1-3 days), higher and longer-lasting IgG titres, higher affinity from memory B cells.
    3. Vaccines exploit memory; active immunity is self-made, passive immunity (antibody transfer) is short-lived.
  2. B

    Hypersensitivity

    1. Type I (IgE on mast cells) is immediate: anaphylaxis, atopy, treated with epinephrine.
    2. Type II is antibody against cell or matrix antigen: hemolytic anaemia, Goodpasture, Graves disease.
    3. Type III is immune-complex deposition with complement: serum sickness, SLE nephritis.
    4. Type IV is T-cell mediated and delayed (48-72 h): contact dermatitis, tuberculin test, type 1 diabetes.
  3. C

    Tolerance and autoimmunity

    1. Central tolerance: clonal deletion of self-reactive T cells in the thymus (AIRE) and receptor editing or deletion in marrow.
    2. Peripheral tolerance: anergy, Treg suppression, deletion, and immune-privileged sites.
    3. Failure causes autoimmune disease, e.g. APECED (AIRE mutation), IPEX (FOXP3 mutation).
  4. D

    Transplantation and immunodeficiency

    1. Hyperacute rejection: preformed antibodies (ABO or HLA) within minutes to hours; acute: T-cell attack weeks to months; chronic: vascular fibrosis over years.
    2. Graft-versus-host disease follows donor T cells attacking host after marrow transplant.
    3. Primary defects include SCID, DiGeorge (thymic aplasia) and complement deficiency; HIV is the main acquired defect.

Lab

  • Sketch primary and secondary antibody-titre curves for IgM and IgG on one axis.
  • Make a hypersensitivity grid (type, effector, timing, example) from memory.

Teach-back prompts

  1. Follow a bacterium entering a finger cut through innate recognition, lymph drainage to a node, T- and B-cell activation, and antibody production.
  2. Compare how a virus-infected cell and an extracellular bacterium are processed and presented, and which T cell responds to each.
  3. Explain how the thymus prevents autoimmunity and what each hypersensitivity type shows when it fails.

Practical targets

  • Thoracic duct and cisterna chyli (NET plate 7)
  • Lymph vessels and nodes of breast (NET plates 190-191)
  • Lymph vessels and nodes of head and neck (NET plate 85)
  • Lymph vessels and nodes of lung (NET plate 212)
  • Spleen in situ and its vessels (NET plate 289)
  • Lymph node: cortex, paracortex, medulla (R&P plate 33)
  • Lymph node: high endothelial venule and sinuses (R&P plate 34)
  • Spleen: white and red pulp (R&P plates 35-36)
  • Thymus: Hassall corpuscle (R&P plate 37)
  • Palatine tonsil: crypt epithelium (R&P plate 32)
  • Germinal centre (Histology Guide MH-076)
  • Central arteriole in white pulp (Histology Guide MH-085)

Also see